Showing results (111-120 of 201) with videos related to

Sort By:
Pageof 21
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 23, 2014
Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survivalJoon Ho Moon, Sang Kyun Sohn, Anna Lambie, et al.
Leukemia & Lymphoma|May 27, 2004
Clinico-biological features and prognostic significance of PML/RARalpha isoforms in adult patients with acute promyelocytic leukemia treated with all trans retinoic acid (ATRA) and chemotherapyVikas Gupta, Qi-Long Yib, Joseph Brandwein, et al.
Haematologica|August 11, 2018
Incidence, outcomes, and risk factors of pleural effusion in patients receiving dasatinib therapy for Philadelphia chromosome-positive leukemiaTimothy P Hughes, Pierre Laneuville, Philippe Rousselot, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 20, 2016
Evaluating the Impact of a Switch to Nilotinib on Imatinib-Related Chronic Low-Grade Adverse Events in Patients With CML-CP: The ENRICH StudyJorge E Cortes, Jeffrey H Lipton, Carole B Miller, et al.
American Journal of Hematology|October 27, 2020
Fresh vs. frozen allogeneic peripheral blood stem cell grafts: A successful timely optionAhmad S Alotaibi, Shruti Prem, Shiyi Chen, et al.
European Journal of Clinical Pharmacology|March 19, 2005
The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietinAnargyros Xenocostas, Wing K Cheung, Francis Farrell, et al.
Acta Haematologica|May 20, 2020
Post-Transplant Cyclophosphamide Combined with Anti-Thymocyte Globulin as Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation in High-Risk Acute Myeloid Leukemia and Myelodysplastic SyndromeWael Alanazi, Shiyi Chen, Jeffrey H Lipton, et al.
British Journal of Haematology|December 9, 2008
Outcomes of older patients (> or = 60 years) with acquired aplastic anaemia treated with immunosuppressive therapySusan Y Kao, Wei Xu, Joseph M Brandwein, et al.
Transplantation|November 22, 2012
Multiple single-nucleotide polymorphism-based risk model for clinical outcomes after allogeneic stem-cell transplantation, especially for acute graft-versus-host diseaseDennis Dong Hwan Kim, Jina Yun, Hong-Hee Won, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 18, 2019
Mobilization of Leukemic Cells Using Plerixafor as Part of a Myeloablative Preparative Regimen for Patients with Acute Myelogenous Leukemia Undergoing Allografting: Assessment of Safety and TolerabilityFotios V Michelis, David W Hedley, Sonal Malhotra, et al.
Pageof 21